Search research articles
Contact Us
Filters
Showing results (1-10 of 10) with videos related to
Page
of 1
Sort By:
Acta Pharmaceutica Sinica. B
|
March 30, 2026
Targeting RNA binding proteins with small-molecule inhibitors: Advances, challenges, and therapeutic opportunities
Yuning Shi, Dazhi Feng, Jieya Zhou, et al.
Journal of Biomolecular Structure & Dynamics
|
January 10, 2024
Discovery of hematopoietic progenitor kinase 1 inhibitors using machine learning-based screening and free energy perturbation
Dazhi Feng, Bo Liu, Zhiwei Chen, et al.
European Journal of Medicinal Chemistry
|
July 7, 2019
Design, synthesis and biological evaluation of novel FFA1/GPR40 agonists: New breakthrough in an old scaffold
Zheng Li, Chunxia Liu, Jianyong Yang, et al.
Bioorganic & Medicinal Chemistry
|
April 21, 2018
Novel fatty acid chain modified GLP-1 derivatives with prolonged in vivo glucose-lowering ability and balanced glucoregulatory activity
Xingguang Cai, Lidan Sun, Yuxuan Dai, et al.
Journal of Medicinal Chemistry
|
July 24, 2025
Overcoming E3 Ligase-Mediated Resistance: Development of Novel Hydrophobic Tagging-Based Degraders Targeting ALK Protein
Shaowen Xie, Jingjie Zhu, Fangyi Zhan, et al.
Journal of Medicinal Chemistry
|
January 23, 2026
Discovery of SY-589, a Highly Potent and Orally Bioavailable Polθ Helicase Inhibitor for the Treatment of HR-Deficient Tumors
Chongxun Ge, Dazhi Feng, Song Shi, et al.
Angewandte Chemie (International Ed. in English)
|
December 23, 2024
In Vivo Self-Assembly of PROTACs by Bioorthogonal Chemistry for Precision Cancer Therapy
Shaowen Xie, Jingjie Zhu, Yihan Peng, et al.
Chemical Science
|
August 6, 2025
Selectively triggered: ROS-activated Michael acceptor prodrug strategy to enhance tumor targeting efficacy
Dazhi Feng, Xinnan Li, Junkai Liu, et al.
Journal of Medicinal Chemistry
|
July 25, 2024
Identification of 6-Fluorine-Substituted Coumarin Analogues as POLRMT Inhibitors with High Potency and Safety for Treatment of Pancreatic Cancer
Shengnan Zhou, Xiaotong Ze, Dazhi Feng, et al.
Journal of Medicinal Chemistry
|
July 29, 2025
Design, Optimization, and Biological Evaluation of a Novel Quinoline-Based POLRMT Inhibitor for Prostate Cancer Therapy
Xinnan Li, Lihua Liu, Dazhi Feng, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 10) with videos related to
Sort By:
Page
of 1
Acta Pharmaceutica Sinica. B
|
March 30, 2026
Targeting RNA binding proteins with small-molecule inhibitors: Advances, challenges, and therapeutic opportunities
Yuning Shi, Dazhi Feng, Jieya Zhou, et al.
Journal of Biomolecular Structure & Dynamics
|
January 10, 2024
Discovery of hematopoietic progenitor kinase 1 inhibitors using machine learning-based screening and free energy perturbation
Dazhi Feng, Bo Liu, Zhiwei Chen, et al.
European Journal of Medicinal Chemistry
|
July 7, 2019
Design, synthesis and biological evaluation of novel FFA1/GPR40 agonists: New breakthrough in an old scaffold
Zheng Li, Chunxia Liu, Jianyong Yang, et al.
Bioorganic & Medicinal Chemistry
|
April 21, 2018
Novel fatty acid chain modified GLP-1 derivatives with prolonged in vivo glucose-lowering ability and balanced glucoregulatory activity
Xingguang Cai, Lidan Sun, Yuxuan Dai, et al.
Journal of Medicinal Chemistry
|
July 24, 2025
Overcoming E3 Ligase-Mediated Resistance: Development of Novel Hydrophobic Tagging-Based Degraders Targeting ALK Protein
Shaowen Xie, Jingjie Zhu, Fangyi Zhan, et al.
Journal of Medicinal Chemistry
|
January 23, 2026
Discovery of SY-589, a Highly Potent and Orally Bioavailable Polθ Helicase Inhibitor for the Treatment of HR-Deficient Tumors
Chongxun Ge, Dazhi Feng, Song Shi, et al.
Angewandte Chemie (International Ed. in English)
|
December 23, 2024
In Vivo Self-Assembly of PROTACs by Bioorthogonal Chemistry for Precision Cancer Therapy
Shaowen Xie, Jingjie Zhu, Yihan Peng, et al.
Chemical Science
|
August 6, 2025
Selectively triggered: ROS-activated Michael acceptor prodrug strategy to enhance tumor targeting efficacy
Dazhi Feng, Xinnan Li, Junkai Liu, et al.
Journal of Medicinal Chemistry
|
July 25, 2024
Identification of 6-Fluorine-Substituted Coumarin Analogues as POLRMT Inhibitors with High Potency and Safety for Treatment of Pancreatic Cancer
Shengnan Zhou, Xiaotong Ze, Dazhi Feng, et al.
Journal of Medicinal Chemistry
|
July 29, 2025
Design, Optimization, and Biological Evaluation of a Novel Quinoline-Based POLRMT Inhibitor for Prostate Cancer Therapy
Xinnan Li, Lihua Liu, Dazhi Feng, et al.
Page
of 1